Search research articles
Contact Us
Filters
Showing results (31-40 of 79) with videos related to
Page
of 8
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
October 1, 1993
Apoptosis of activated CD8+/CD57+ T cells is induced by some combinations of anti-CD2 mAb
M Rouleau, A Bernard, O Lantz, et al.
Journal of Immunological Methods
|
March 1, 1991
EBV cell-lines (LCL) and E- cells as stimulator cells for limiting dilution analysis (LDA) of alloreactive IL-2-secreting cells (IL-2-SC) and cytotoxic precursors (CTLp). Comparison of their stimulator capacity and ability to generate specific alloreactivity
O Lantz, P Alard, G Chavanel, et al.
Cellular Immunology
|
April 1, 1979
Enhancement by interferon of natural killer cell activity in mice
A Senik, I Gresser, C Maury, et al.
Transplantation Proceedings
|
March 1, 1979
Enhancement of mouse NK cells by interferon
A Senik, I Gresser, C Maury, et al.
Transplantation Proceedings
|
February 1, 1989
Suppressive phenomena and absence of clonal deletion evidenced by limiting dilution analysis (LDA) of donor-specific IL2 secreting cells (IL2 SC) and cytotoxic precursors (CTLp)
O Lantz, P Alard, H Ben Aribia, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 15, 1986
Regulation of immunoglobulin synthesis by human T cell subsets as defined by anti-D44 monoclonal antibody within the CD4+ and CD8+ subpopulations
C F Calvo, A Bernard, S Huet, et al.
Transplantation Proceedings
|
February 1, 1995
Some combinations of anti-CD2 MAb induce apoptosis of activated CD8+/CD57+ T cells
M Rouleau, A Bernard, O Lantz, et al.
Transplantation
|
February 1, 1993
A possible role for specific "anergy" in immunologic hyporeactivity to donor stimulation in human kidney allograft recipients
P Alard, O Lantz, J Y Perrot, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 1, 1984
Preferential elimination of NK and CTL functions by anti-D44 monoclonal antibody
C F Calvo, L Boumsell, J P Kolb, et al.
Kardiologiia
|
June 1, 1978
[Use of the preparation Essenciale in chronic ischemic heart disease]
V G Kukes, E A Senik, E T Gneushev, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 79) with videos related to
Sort By:
Page
of 8
Journal of Immunology (Baltimore, Md. : 1950)
|
October 1, 1993
Apoptosis of activated CD8+/CD57+ T cells is induced by some combinations of anti-CD2 mAb
M Rouleau, A Bernard, O Lantz, et al.
Journal of Immunological Methods
|
March 1, 1991
EBV cell-lines (LCL) and E- cells as stimulator cells for limiting dilution analysis (LDA) of alloreactive IL-2-secreting cells (IL-2-SC) and cytotoxic precursors (CTLp). Comparison of their stimulator capacity and ability to generate specific alloreactivity
O Lantz, P Alard, G Chavanel, et al.
Cellular Immunology
|
April 1, 1979
Enhancement by interferon of natural killer cell activity in mice
A Senik, I Gresser, C Maury, et al.
Transplantation Proceedings
|
March 1, 1979
Enhancement of mouse NK cells by interferon
A Senik, I Gresser, C Maury, et al.
Transplantation Proceedings
|
February 1, 1989
Suppressive phenomena and absence of clonal deletion evidenced by limiting dilution analysis (LDA) of donor-specific IL2 secreting cells (IL2 SC) and cytotoxic precursors (CTLp)
O Lantz, P Alard, H Ben Aribia, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 15, 1986
Regulation of immunoglobulin synthesis by human T cell subsets as defined by anti-D44 monoclonal antibody within the CD4+ and CD8+ subpopulations
C F Calvo, A Bernard, S Huet, et al.
Transplantation Proceedings
|
February 1, 1995
Some combinations of anti-CD2 MAb induce apoptosis of activated CD8+/CD57+ T cells
M Rouleau, A Bernard, O Lantz, et al.
Transplantation
|
February 1, 1993
A possible role for specific "anergy" in immunologic hyporeactivity to donor stimulation in human kidney allograft recipients
P Alard, O Lantz, J Y Perrot, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 1, 1984
Preferential elimination of NK and CTL functions by anti-D44 monoclonal antibody
C F Calvo, L Boumsell, J P Kolb, et al.
Kardiologiia
|
June 1, 1978
[Use of the preparation Essenciale in chronic ischemic heart disease]
V G Kukes, E A Senik, E T Gneushev, et al.
Page
of 8